ANRO vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ANRO Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Alto Neuroscience Inc. (ANRO) driven by superior Growth & Margin, Momentum & Technical while ENSC counters with relative strength in Valuation, Options & Structure. Fundamentally, ANRO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, ANRO sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ANRO | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $7.0M | Larger Scale | ANRO |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | +0.0% | -15.1% | Higher Growth | ANRO |
| Operating Margin (TTM) Profitability | 0.0% | -281.3% | Higher Margin | ANRO |
| Net Profit Margin Profitability | 0.0% | -280.5% | Higher Margin | ANRO |
| Return on Equity (ROE) Capital Efficiency | -46.7% | -1295.1% | Higher ROE | ANRO |
| 52-Week Range Position Momentum | 52% ($13โ$37) | 8% ($0โ$2) | Stronger Trend | ANRO |
| Beta / 30D Volatility Risk Regime | 1.86ฮฒ ยท 91% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 45.8 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |